SCHEMBL29066564

SCHEMBL29066564

CCC(=O)CC[C@H](C)[C@H](N)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 2/20 0.44
GABRP O00591 2/20 0.40
GABRD O14764 2/20 0.40
GABRA1 P14867 2/20 0.40
GABRB1 P18505 2/20 0.40
GABRG2 P18507 2/20 0.40
GABRB3 P28472 2/20 0.40
GABRA5 P31644 2/20 0.40
GABRA3 P34903 2/20 0.40
GABRA2 P47869 2/20 0.40
GABRB2 P47870 2/20 0.40
GABRA4 P48169 2/20 0.40
GABRE P78334 2/20 0.40
GABRA6 Q16445 2/20 0.40
GABRG1 Q8N1C3 2/20 0.40
GABRG3 Q99928 2/20 0.40
GABRQ Q9UN88 2/20 0.40
LTA4H P09960 1/20 0.36
ALDH1A1 P00352 1/20 0.36
TDP1 Q9NUW8 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8641185 0.86 SLC7A5 (0.43) SLC7A5GABRPGABRDGABRA1GABRB1
SCHEMBL15673290 0.84 SLC7A5 (0.41) SLC7A5GABRPGABRDGABRA1GABRB1
SCHEMBL4716019 0.83 GABRP (0.60) SLC7A5GABRPGABRDGABRA1GABRB1
SCHEMBL28559454 0.82 KDM4E (0.45) SLC7A5GABRPGABRDGABRA1GABRB1
SCHEMBL15649084 0.82 KMT2A (0.52) ALDH1A1TDP1GRIK1GRIK2ALOX15
SCHEMBL13279300 0.82 KMT2A (0.52) ALDH1A1TDP1GRIK1GRIK2ALOX15
SCHEMBL15650629 0.82 KMT2A (0.52) ALDH1A1TDP1GRIK1GRIK2ALOX15
SCHEMBL23420704 0.81 SLC7A5 (0.46) SLC7A5GABRPGABRDGABRA1GABRB1
SCHEMBL1236551 0.81 ALOX15 (0.56) SLC7A5GABRPGABRDGABRA1GABRB1
SCHEMBL5320168 0.81 ALOX15 (0.56) SLC7A5GABRPGABRDGABRA1GABRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116546988-A Prodrugs of 5α -hydroxy-6β - [2- (1H-imidazol-4-yl) ethylamino ] cholestan-3β -ol and pharmaceutical compositions for cancer treatment containing the same 登德罗杰尼克斯公司 2023-08-04 CN disclosed